The V617F JAK2 mutation and the myeloproliferative disorders.

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{a98c27ce47b245be9e9fd8f5294b5ba4,

title = "The V617F JAK2 mutation and the myeloproliferative disorders.",

author = "M.J. Percy and Mary McMullin",

year = "2005",

month = sep,

doi = "10.1002/hon.761",

language = "English",

volume = "23(3-4)",

pages = "91--93",

journal = "Hematological Oncology",

publisher = "Wiley-Blackwell",

number = "3-4",

}

TY - JOUR

T1 - The V617F JAK2 mutation and the myeloproliferative disorders.

AU - Percy, M.J.

AU - McMullin, Mary

PY - 2005/9

Y1 - 2005/9

UR - http://www.scopus.com/inward/record.url?scp=30344484239&partnerID=8YFLogxK

U2 - 10.1002/hon.761

DO - 10.1002/hon.761

M3 - Article

C2 - 16285006

VL - 23(3-4)

SP - 91

EP - 93

JO - Hematological Oncology

JF - Hematological Oncology

IS - 3-4

ER -